SCHEMBL19258536

SCHEMBL19258536

CCn1ncc2cnccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HASPIN Q8TF76 1/20 0.53
HDAC8 Q9BY41 1/20 0.38
RPS6KA5 O75582 7/20 0.37
POLB P06746 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RECQL P46063 1/20 0.37
RPS6KB1 P23443 1/20 0.35
CDK2 P24941 1/20 0.35
ROCK1 Q13464 1/20 0.35
DYRK1A Q13627 1/20 0.35
RPS6KA1 Q15418 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29989046 0.85 HASPIN (0.49) HASPINRPS6KA5POLBKDM4ENPC1
SCHEMBL21501930 0.85 HASPIN (0.49) HASPINRPS6KA5POLBKDM4ENPC1
SCHEMBL18926933 0.80 HTR2A (0.44) HASPINHDAC8RECQLROCK1DYRK1A
SCHEMBL29491253 0.77 HTR2A (0.44) HASPINHDAC8RECQLMKNK2HTR2C
SCHEMBL28667718 0.76 RECQL (0.49) KDM4ENPC1ALDH1A1LMNAMAPT
SCHEMBL13217 0.76 RECQL (0.61) POLBNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL1717344 0.75 KMO (0.55) HDAC8POLBKDM4EHPGDHSD17B10
SCHEMBL29958837 0.74 CDK8 (0.43) HASPINHDAC8RPS6KA5NPC1TP53
SCHEMBL256359 0.74 CDK8 (0.43) HASPINHDAC8RPS6KA5NPC1TP53
SCHEMBL18939024 0.73 CYP19A1 (0.50) KDM4EALDH1A1LMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133657-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed